insights_auto
Why is EDIT down 3,01%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,77 US$
arrow_downward
-3,01%(-0,055) 1D
1,81 US$
arrow_upward
+2,26% (+0,040)bedtimeAfter hours
Closed: 18 ნოე, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,86 US$
High
1,94 US$
Low
1,76 US$
Mkt. cap
272,43 მლნ.
Avg. vol.
2,39 მლნ.
Volume
0,00
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
Open
1,86 US$
High
1,94 US$
Low
1,76 US$
Mkt. cap
272,43 მლნ.
Avg. vol.
2,39 მლნ.
Volume
0,00
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
News stories
From web sources and news partners
BigGo Finance
·
1 საათის წინ
UBS Sets S&P 500 Target of 8,200 by End-2027, Implying Roughly 12% Upside, But Cuts Rating to Neutral
TradingView
·
1 საათის წინ
Nasdaq, Dow, S&P 500 Futures Climb Ahead Of Anthropic’s Record Debut: SLS, GLD, TTWO, UNH In Focus
FOREX.com
·
27 წუთის წინ
S&P 500 Grasps At Support as Surging Hike Odds, Treasury Yields Threaten Larger Turn
Traders Union
·
3 საათის წინ
S&P 500 dips below 200-day average after long streak, Ryan Detrick notes
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc